相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international consensus classification approach COMMENT
Daniel A. Arber et al.
AMERICAN JOURNAL OF HEMATOLOGY (2022)
DNMT3A overgrowth syndrome is associated with the development of hematopoietic malignancies in children and young adults
Margaret A. Ferris et al.
BLOOD (2022)
Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome
Tim Grob et al.
BLOOD (2022)
Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia
Shunsuke Kimura et al.
BLOOD (2022)
Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001
Thai Hoa Tran et al.
BLOOD ADVANCES (2022)
TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML
Olga K. Weinberg et al.
BLOOD ADVANCES (2022)
Mutational Landscape of TdT+ Large B-cell Lymphomas Supports Their Distinction From B-lymphoblastic Neoplasms A Multiparameter Study of a Rare and Aggressive Entity
Shweta Bhavsar et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2022)
Distinguishing AML from MDS: a fixed blast percentage may no longer be optimal
Elihu Estey et al.
BLOOD (2022)
Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL
Marie Passet et al.
BLOOD (2022)
N-terminus DUX4-immunohistochemistry is a reliable methodology for the diagnosis of DUX4-fused B-lymphoblastic leukemia/lymphoma (N-terminus DUX4 IHC for DUX4-fused B-ALL)
Bradford J. Siegele et al.
GENES CHROMOSOMES & CANCER (2022)
Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis
Roberta Zanotti et al.
LEUKEMIA (2022)
Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion-associated myeloid neoplasm
Oriana Miltiadous et al.
BLOOD ADVANCES (2022)
Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia
Satoshi Wakita et al.
BLOOD ADVANCES (2022)
Frequency and prognostic impact of ZEB2 H1038 and Q1072 mutations in childhood B-other acute lymphoblastic leukemia
Marketa Zaliova et al.
HAEMATOLOGICA (2021)
Mutation landscape, clonal evolution pattern, and potential pathogenic pathways in B-lymphoblastic transformation of follicular lymphoma
Kui Nie et al.
LEUKEMIA (2021)
Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS
A. Kuendgen et al.
LEUKEMIA (2021)
Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2
Olga Pozdnyakova et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)
Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline Disorders Report of the 2019 Society for Hematopathology/European Association for Haematopathology Workshop
Katalin Kelemen et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)
Comparison of myeloid blast counts and variant allele frequencies of gene mutations in myelodysplastic syndrome with excess blasts and secondary acute myeloid leukemia
Xueyan Chen et al.
LEUKEMIA & LYMPHOMA (2021)
Targeted sequencing to identify genetic alterations and prognostic markers in pediatric T-cell acute lymphoblastic leukemia
Ya-Hsuan Chang et al.
SCIENTIFIC REPORTS (2021)
Outcome of T-cell acute lymphoblastic leukemia/lymphoma: Focus on near-ETP phenotype and differential impact of nelarabine
Kiyomi Morita et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study
Sabine Kayser et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Clinicopathological characterisation of myeloproliferative neoplasm-unclassifiable (MPN-U): a retrospective analysis from a large UK tertiary referral centre
Paul Deschamps et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes
Sushree S. Sahoo et al.
NATURE MEDICINE (2021)
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes
Matteo Bersanelli et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group
Shinsuke Hirabayashi et al.
LEUKEMIA (2021)
Myelodysplastic syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 better classified as acute myeloid leukemia? A multicenter study of 107 cases
Hong Fang et al.
MODERN PATHOLOGY (2021)
Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome
Alyssa L. Kennedy et al.
NATURE COMMUNICATIONS (2021)
CD3-CD4+ Lymphocytic Variant Hypereosinophilic Syndrome: Diagnostic Tools Revisited
Caroline Carpentier et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis
Paola Guglielmelli et al.
BLOOD CANCER JOURNAL (2021)
Clinical, genomic, and transcriptomic differences between myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) and myelodysplastic syndrome with ring sideroblasts (MDS-RS)
Guillermo Montalban-Bravo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology Group
Katherine Tarlock et al.
BLOOD (2021)
Blast and accelerated phase CML: room for improvement
Joan How et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2021)
Systematic application of fluorescence in situ hybridization and immunophenotype profile for the identification of ZNF384 gene rearrangements in B cell acute lymphoblastic leukemia
Nancy Beryl Janet et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2021)
Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells
Melvin E. Thomas et al.
LEUKEMIA (2021)
Myeloid/lymphoid neoplasms with FLT3 rearrangement
Guilin Tang et al.
MODERN PATHOLOGY (2021)
Myelodysplastic syndromes with no somatic mutations detected by next-generation sequencing display similar features to myelodysplastic syndromes with detectable mutations
Sa A. Wang et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Relationship between clone metrics and clinical outcome in clonal cytopenia
Anna Galli et al.
BLOOD (2021)
CEBPA Mutations in 4708 Patients with Acute Myeloid Leukemia - Differential Impact of bZIP and TAD Mutations on Outcome
Franziska Taube et al.
BLOOD (2021)
B-cell lymphoma/leukaemia 11B (BCL11B) expression status helps distinguish early T-cell precursor acute lymphoblastic leukaemia/lymphoma (ETP-ALL/LBL) from other subtypes of T-cell ALL/LBL
Hong Fang et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Current Management of Chronic Neutrophilic Leukemia
Natasha Szuber et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2021)
Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study
Judith M. Boer et al.
LEUKEMIA (2021)
Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity
Peter Valent et al.
SEMINARS IN IMMUNOPATHOLOGY (2021)
Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia
Lindsey E. Montefiori et al.
CANCER DISCOVERY (2021)
T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness
Valentina Bardelli et al.
GENES (2021)
Biologic and Therapeutic Implications of Genomic Alterations in Acute Lymphoblastic Leukemia
Ilaria Iacobucci et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Integration of Molecular Information in Risk Assessment of Patients with Myeloproliferative Neoplasms
Giuseppe G. Loscocco et al.
CELLS (2021)
Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification
Inge van der Werf et al.
BLOOD ADVANCES (2021)
Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistance
Justin Anthony Chen et al.
BLOOD ADVANCES (2021)
Juvenile myelomonocytic leukemia in the molecular era: a clinician's guide to diagnosis, risk stratification, and treatment
Astrid Wintering et al.
BLOOD ADVANCES (2021)
A novel class of ZNF384 aberrations in acute leukemia
Marketa Zaliova et al.
BLOOD ADVANCES (2021)
Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal
Peter Valent et al.
HEMASPHERE (2021)
Myeloid Neoplasm with PDGFRA Rearrangement Manifesting as a Retromolar Pad Mass
Amy S. Duffield et al.
HEAD & NECK PATHOLOGY (2021)
T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies
Valentina Cordo et al.
BLOOD CANCER DISCOVERY (2021)
Fusion driven JMML: a novel CCDC88C-FLT3 fusion responsive to sorafenib identified by RNA sequencing
Alexander K. Chao et al.
LEUKEMIA (2020)
Familial myeloid malignancies with germline TET2 mutation
Nicolas Duployez et al.
LEUKEMIA (2020)
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
A. Hochhaus et al.
LEUKEMIA (2020)
Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes
Juliana Schwaab et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia
Robert P. Hasserjian et al.
BLOOD (2020)
SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS
Luca Malcovati et al.
BLOOD (2020)
Concordance among hematopathologists in classifying blasts plus promonocytes: A bone marrow pathology group study
Kathryn Foucar et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2020)
Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes
Sushree S. Sahoo et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2020)
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms
Laura Palomo et al.
BLOOD (2020)
Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP-BFM acute lymphoblastic leukemia protocol
Mareike Jung et al.
GENES CHROMOSOMES & CANCER (2020)
Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results
Claude Gardin et al.
BLOOD ADVANCES (2020)
Chronic myeloid leukemia presenting in lymphoblastic crisis, a differential diagnosis with Philadelphia-positive B-lymphoblastic leukemia
Zhining Chen et al.
LEUKEMIA & LYMPHOMA (2020)
Machine learning demonstrates that somatic mutations imprint invariant morphologic features in myelodysplastic syndromes
Yasunobu Nagata et al.
BLOOD (2020)
Implications ofTP53allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
Elsa Bernard et al.
NATURE MEDICINE (2020)
Chronic Myeloid Leukemia, Version 2.2021
Michael W. Deininger et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
Reclassification of subtypes in Philadelphia chromosome-negative myeloproliferative neoplasm by 2016 WHO diagnostic criteria: focus on the cases classified as myeloproliferative neoplasm, unclassifiable by the 2008 version
Jiwon Yun et al.
LEUKEMIA & LYMPHOMA (2020)
NPM1-Mutated Myeloid Neoplasms with <20% Blasts: A Really Distinct Clinico-Pathologic Entity?
Fabio Forghieri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease
David B. Beck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features
Xavier Calvo et al.
BLOOD ADVANCES (2020)
Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies
Amy M. Trottier et al.
BLOOD ADVANCES (2020)
Clinical and molecular characteristics of MEF2D fusion-positive B-cell precursor acute lymphoblastic leukemia in childhood, including a novel translocation resulting in MEF2D-HNRNPH1 gene fusion
Kentaro Ohki et al.
HAEMATOLOGICA (2019)
Genetic predisposition to MDS: clinical features and clonal evolution
Alyssa L. Kennedy et al.
BLOOD (2019)
Juvenile myelomonocytic leukemia: who's the driver at the wheel?
Charlotte M. Niemeyer et al.
BLOOD (2019)
Familial predisposition to TP53/complex karyotype MDS and leukemia in DNA repair-deficient xeroderma pigmentosum
Alain Sarasin et al.
BLOOD (2019)
CD371 cell surface expression: A unique feature of DUX4-rearranged acute lymphoblastic leukemia
Dagmar Schinnerl et al.
HAEMATOLOGICA (2019)
Durable remissions in TCF3-HLF positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantation
Brice Mouttet et al.
HAEMATOLOGICA (2019)
NUTM1 is a recurrent fusion gene partner in B-cell precursor acute lymphoblastic leukemia associated with increased expression of genes on chromosome band 10p12.31-12.2
Femke M. Hormann et al.
HAEMATOLOGICA (2019)
PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia
Lorenz Bastian et al.
LEUKEMIA (2019)
ERCC6L2 defines a novel entity within inherited acute myeloid leukemia
Suvi P. M. Douglas et al.
BLOOD (2019)
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions
Peter Valent et al.
HAEMATOLOGICA (2019)
Variant allele frequencies do not correlate well with myeloblast counts in a clinically validated gene sequencing panel for routine acute myeloid leukemia workup
Laura N. Toth et al.
LEUKEMIA & LYMPHOMA (2019)
Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin
Michael Lauseker et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements
Ilaria Tanasi et al.
BLOOD (2019)
Addressing and proposing solutions for unmet clinical needs in the management of myeloproliferative neoplasm-associated thrombosis: A consensus-based position paper
Tiziano Barbui et al.
BLOOD CANCER JOURNAL (2019)
Noonan syndrome-associated myeloproliferative disorder with somatically acquired monosomy 7: impact on clinical decision making
Mattias Hofmans et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome
Marie Passet et al.
BLOOD (2019)
The use of targeted sequencing and flow cytometry to identify patients with a clinically significant monocytosis
Catherine Cargo et al.
BLOOD (2019)
Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia
Nicholas C. P. Cross et al.
LEUKEMIA (2019)
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups
Detlef Haase et al.
LEUKEMIA (2019)
Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study
Guilin Tang et al.
MODERN PATHOLOGY (2019)
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
Zhaohui Gu et al.
NATURE GENETICS (2019)
Bone Marrow Morphology Associated With Germline RUNX1 Mutations in Patients With Familial Platelet Disorder With Associated Myeloid Malignancy
Karen M. Chisholm et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2019)
Hematologic malignancies and Li-Fraumeni syndrome
Mahesh Swaminathan et al.
COLD SPRING HARBOR MOLECULAR CASE STUDIES (2019)
Clinicopathologic and genetic characterization of nonacute NPM1-mutated myeloid neoplasms
Sanjay S. Patel et al.
BLOOD ADVANCES (2019)
NPM1 mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapy
Guillermo Montalban-Bravo et al.
BLOOD ADVANCES (2019)
Impact of constitutional TET2 haploinsufficiency on molecular and clinical phenotype in humans
Eevi Kaasinen et al.
NATURE COMMUNICATIONS (2019)
MDS1 and EVI1 complex locus (MECOM): a novel candidate gene for hereditary hematological malignancies
Tim Ripperger et al.
HAEMATOLOGICA (2018)
Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies
Giovanni Cazzaniga et al.
HAEMATOLOGICA (2018)
Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia
Bing Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
MDS1 and EVI1 complex locus (MECOM): a novel candidate gene for hereditary hematological malignancies
Tim Ripperger et al.
HAEMATOLOGICA (2018)
Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies
Giovanni Cazzaniga et al.
HAEMATOLOGICA (2018)
A Test Utilization Approach to the Diagnostic Workup of Isolated Eosinophilia in Otherwise Morphologically Unremarkable Bone Marrow A Single Institutional Experience
Hong Fang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2018)
Integrated molecular profiling of juvenile myelomonocytic leukemia
Norihiro Murakami et al.
BLOOD (2018)
ETV6-NTRK3 induces aggressive acute lymphoblastic leukemia highly sensitive to selective TRK inhibition
Kathryn G. Roberts et al.
BLOOD (2018)
Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia
Michelle L. Churchman et al.
CANCER CELL (2018)
FGFR1 translocation with concurrent myeloproliferative neoplasm, systemic mastocytosis, and lymphoblastic lymphoma: a case report
Koping Chang et al.
HUMAN PATHOLOGY (2018)
TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children
Maoxiang Qian et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
The division of chronic myelomonocytic leukemia (CMML)-1 into CMML-0 and CMML-1 according to 2016 World Health Organization (WHO) classification has no impact in outcome in a large series of patients from the Spanish group of MDS
Blanca Xicoy et al.
LEUKEMIA RESEARCH (2018)
The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion
Tiziano Barbui et al.
BLOOD CANCER JOURNAL (2018)
CSF3R-mutated chronic neutrophilic leukemia: long-term outcome in 19 consecutive patients and risk model for survival
Natasha Szuber et al.
BLOOD CANCER JOURNAL (2018)
MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AML
Mathijs A. Sanders et al.
BLOOD (2018)
Donor-derived MDS/AML in families with germline GATA2 mutation
Pallavi Galera et al.
BLOOD (2018)
The genetic basis and cell of origin of mixed phenotype acute leukaemia
Thomas B. Alexander et al.
NATURE (2018)
Myeloproliferative neoplasm with ABL1/ETV6 rearrangement mimics chronic myeloid leukemia and responds to tyrosine kinase inhibitors
Wei Xie et al.
CANCER GENETICS (2018)
IG-MYC plus neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas
Rabea Wagener et al.
BLOOD (2018)
Bone Marrow Core Biopsy in 508 Consecutive Patients With Chronic Myeloid Leukemia: Assessment of Potential Value
Juliana E. Hidalgo-Lopez et al.
CANCER (2018)
Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases
Jian-Feng Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Prefibrotic myelofibrosis: treatment algorithm 2018
Guido Finazzi et al.
BLOOD CANCER JOURNAL (2018)
Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories
Sanam Loghavi et al.
BLOOD ADVANCES (2018)
Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts
Peter Valent et al.
BLOOD (2017)
ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype
Shinsuke Hirabayashi et al.
HAEMATOLOGICA (2017)
A novel t(3;13)(q13;q12) translocation fusing FLT3 with GOLGB1: toward myeloid/lymphoid neoplasms with eosinophilia and rearrangement of FLT3?
E. Troadec et al.
LEUKEMIA (2017)
Mutational landscape in children with myelodysplastic syndromes is distinct from adults: specific somatic drivers and novel germline variants
V. Pastor et al.
LEUKEMIA (2017)
The myeloproliferative neoplasms, unclassifiable: clinical and pathological considerations
Umberto Gianelli et al.
MODERN PATHOLOGY (2017)
ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype
Shinsuke Hirabayashi et al.
HAEMATOLOGICA (2017)
ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype
Marketa Zaliova et al.
GENES CHROMOSOMES & CANCER (2017)
Mutated ASXL1 and number of somatic mutations as possible indicators of progression to chronic myelomonocytic leukemia of myelodysplastic syndromes with single or multilineage dysplasia
Ana Valencia-Martinez et al.
HAEMATOLOGICA (2017)
Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome
Sa A. Wang et al.
HAEMATOLOGICA (2017)
Inherited thrombocytopenia caused by ANKRD26 mutations misdiagnosed and treated as myelodysplastic syndrome: report on two cases
C. Zaninetti et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study
Koichi Takahashi et al.
LANCET ONCOLOGY (2017)
Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation
S. Kobayashi et al.
LEUKEMIA (2017)
Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia
M. Jawhar et al.
LEUKEMIA (2017)
Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia
Julia T. Geyer et al.
MODERN PATHOLOGY (2017)
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
Yu Liu et al.
NATURE GENETICS (2017)
Transient juvenile myelomonocytic leukemia in the setting of PTPN11 mutation and Noonan syndrome with secondary development of monosomy 7
Katrina O'Halloran et al.
PEDIATRIC BLOOD & CANCER (2017)
The genomic landscape of pediatric myelodysplastic syndromes
Jason R. Schwartz et al.
NATURE COMMUNICATIONS (2017)
A novel TRIP11-FLT3 fusion in a patient with a myeloid/lymphoid neoplasm with eosinophilia
Alfred Chung et al.
CANCER GENETICS (2017)
Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria
Elisa Rumi et al.
ONCOTARGET (2017)
Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia
Yuan Ouyang et al.
ONCOTARGET (2017)
Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions
Peter Valent et al.
ONCOTARGET (2017)
Inherited TP53 Mutations and the Li-Fraumeni Syndrome
Tanya Guha et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia
Kim-Hien T. Dao et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2017)
Mutated ASXL1 and number of somatic mutations as possible indicators of progression to chronic myelomonocytic leukemia of myelodysplastic syndromes with single or multilineage dysplasia
Ana Valencia-Martinez et al.
HAEMATOLOGICA (2017)
Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome
Sa A. Wang et al.
HAEMATOLOGICA (2017)
Idiopathic hypereosinophilia is clonal disorder? Clonality identified by targeted sequencing
Jee-Soo Lee et al.
PLOS ONE (2017)
Philadelphia chromosome-like acute lymphoblastic leukemia
Sarah K. Tasian et al.
BLOOD (2017)
Nucleophosmin 1 (NPM1) mutations in chronic myelomonocytic leukemia and their prognostic relevance
Rangit Vallapureddy et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Pre-fibrotic/early primary myelofibrosis vs. WHO-defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease
Georg Jeryczynski et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Accumulation of classical monocytes defines a subgroup of MDS that frequently evolves into CMML
Dorothee Selimoglu-Buet et al.
BLOOD (2017)
Myelodysplastic Syndrome, Unclassifiable (MDS-U) With 1% Blasts Is a Distinct Subgroup of MDS-U With a Poor Prognosis
Elizabeth Margolskee et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2017)
Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis
Paola Guglielmelli et al.
BLOOD (2017)
Clinical significance of somatic mutation in unexplained blood cytopenia
Luca Malcovati et al.
BLOOD (2017)
Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology
Lenka Hovorkova et al.
BLOOD (2017)
Bloom's Syndrome: Clinical Spectrum, Molecular Pathogenesis, and Cancer Predisposition
Christopher Cunniff et al.
MOLECULAR SYNDROMOLOGY (2017)
Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents
Marcin W. Wlodarski et al.
BLOOD (2016)
Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria
H. Gisslinger et al.
LEUKEMIA (2016)
Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Is Separated into Two Subgroups Associated with Survival by BCR-ABL Fluorescence in situ Hybridization of Segmented Cell Nuclei: Report from a Single Institution
Yoshimasa Kamoda et al.
ACTA HAEMATOLOGICA (2016)
Interactions and relevance of blast percentage and treatment strategy among younger and older patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)
Courtney D. DiNardo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes
Peter L. Greenberg et al.
BLOOD (2016)
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia
Chiara Elena et al.
BLOOD (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
The current perspective of low-grade myelodysplastic syndrome in children
Daisuke Hasegawa
INTERNATIONAL JOURNAL OF HEMATOLOGY (2016)
Predictors of survival in WHO-defined hypereosinophilic syndrome and idiopathic hypereosinophilia and the role of next-generation sequencing
A. Pardanani et al.
LEUKEMIA (2016)
Double- and triple-hit lymphomas can present with features suggestive of immaturity, including TdT expression, and create diagnostic challenges
Laura Moench et al.
LEUKEMIA & LYMPHOMA (2016)
Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified
Sa A. Wang et al.
MODERN PATHOLOGY (2016)
Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults
Takahiko Yasuda et al.
NATURE GENETICS (2016)
Deregulation of DUX4 and ERG in acute lymphoblastic leukemia
Jinghui Zhang et al.
NATURE GENETICS (2016)
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Frequency and outcome of pediatric acute lymphoblastic leukemia with ZNF384 gene rearrangements including a novel translocation resulting in an ARID1B/ZNF384 gene fusion
Mary Shago et al.
PEDIATRIC BLOOD & CANCER (2016)
Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia
Henrik Lilljebjorn et al.
NATURE COMMUNICATIONS (2016)
Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia
Zhaohui Gu et al.
NATURE COMMUNICATIONS (2016)
JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities
Katherine R. Calvo et al.
BLOOD (2015)
Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers
Gaelle Bougeard et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort
N. Lavoine et al.
JOURNAL OF MEDICAL GENETICS (2015)
Reproducibility and prognostic significance of morphologic dysplasia in de novo acute myeloid leukemia
Olga K. Weinberg et al.
MODERN PATHOLOGY (2015)
Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options
Ute Fischer et al.
NATURE GENETICS (2015)
Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia
T. Yoshizato et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts
Patricia Font et al.
ANNALS OF HEMATOLOGY (2015)
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
R. Coleman Lindsley et al.
BLOOD (2015)
Predicting Early Blast Transformation in Chronic-Phase Chronic Myeloid Leukemia: Is Immunophenotyping the Missing Link?
Fuad El Rassi et al.
CANCER (2015)
Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity
Michael Y. Zhang et al.
HAEMATOLOGICA (2015)
Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations
Robert S. Ohgami et al.
MODERN PATHOLOGY (2015)
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes
M. G. Della Porta et al.
LEUKEMIA (2015)
Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal
P. Valent et al.
ANNALS OF ONCOLOGY (2014)
Two splice-factor mutant leukemia subgroups uncovered at the boundaries of MDS and AML using combined gene expression and DNA-methylation profiling
Erdogan Taskesen et al.
BLOOD (2014)
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms
Sa A. Wang et al.
BLOOD (2014)
Clinical characteristics and treatment outcome in 65 cases with refractory cytopenia of childhood defined according to the WHO 2008 classification
Daisuke Hasegawa et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood
Ayami Yoshimi et al.
HAEMATOLOGICA (2014)
Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study
Heesun J. Rogers et al.
HAEMATOLOGICA (2014)
Cytogenetics and clinical features of pediatric myelodysplastic syndrome in Japan
Koichi Moriwaki et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2014)
Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM
Ivan Alvarez-Twose et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium Care for CMMR-D (C4CMMR-D)
H. F. A. Vasen et al.
JOURNAL OF MEDICAL GENETICS (2014)
Juvenile myelomonocytic leukaemia and Noonan syndrome
Marion Strullu et al.
JOURNAL OF MEDICAL GENETICS (2014)
Inherited susceptibility to pre B-ALL caused by germline transmission of PAX5 c. 547G>A
F. Auer et al.
LEUKEMIA (2014)
Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status
M. Schmidt et al.
LEUKEMIA (2014)
ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients
M. M. Patnaik et al.
LEUKEMIA (2014)
Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemias
E. Schuler et al.
LEUKEMIA RESEARCH (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: Clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components
Sa A. Wang et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia
Esperanza Such et al.
BLOOD (2013)
High incidence of Fanconi anaemia in patients with a morphological picture consistent with refractory cytopenia of childhood
Ayami Yoshimi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
Raphael Itzykson et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease
Leonardo Boiocchi et al.
MODERN PATHOLOGY (2013)
CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia
A. Pardanani et al.
LEUKEMIA (2013)
Age, JAK2V617F and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis
J. Broseus et al.
LEUKEMIA (2013)
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study
J. V. Jovanovic et al.
LEUKEMIA (2013)
The genomic landscape of hypodiploid acute lymphoblastic leukemia
Linda Holmfeldt et al.
NATURE GENETICS (2013)
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia
Sohela Shah et al.
NATURE GENETICS (2013)
WHO Classification of Myeloproliferative Neoplasms (MPN): A Critical Update
Hans Michael Kvasnicka
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2013)
Exome Sequencing Identifies Autosomal-Dominant SRP72 Mutations Associated with Familial Aplasia and Myelodysplasia
Michael Kirwan et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome
Frank G. Rueckner et al.
BLOOD (2012)
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
Manja Meggendorfer et al.
BLOOD (2012)
Multilineage dysplasia does not influence prognosis in CEBPA-mutated AML, supporting the WHO proposal to classify these patients as a unique entity
Ulrike Bacher et al.
BLOOD (2012)
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg et al.
BLOOD (2012)
PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies
Francois P. Duhoux et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Morphological differentiation of severe aplastic anaemia from hypocellular refractory cytopenia of childhood: reproducibility of histopathological diagnostic criteria
Irith Baumann et al.
HISTOPATHOLOGY (2012)
Myelodysplastic Syndrome With inv(3)(q21q26.2) or t(3;3)(q21;q26.2) Has a High Risk for Progression to Acute Myeloid Leukemia
Wei Cui et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation
Haowen Xiao et al.
BLOOD (2011)
Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification
Juergen Thiele et al.
BLOOD (2011)
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
Elias Campo et al.
BLOOD (2011)
Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemia
Thomas Ernst et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
Tiziano Barbui et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The inv(3)(q21q26)/t(3;3)(q21;q26) is frequently accompanied by alterations of the RUNX1, KRAS and NRAS and NF1 genes and mediates adverse prognosis both in MDS and in AML: a study in 39 cases of MDS or AML
C. Haferlach et al.
LEUKEMIA (2011)
Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1)
Brunangelo Falini et al.
BLOOD (2010)
The prognostic value of multilineage dysplasia in de novo acute myeloid leukemia patients with intermediate-risk cytogenetics is dependent on NPM1 mutational status
Marina Diaz-Beya et al.
BLOOD (2010)
Mutations of the Shwachman-Bodian-Diamond syndrome gene in patients presenting with refractory cytopenia - do we have to screen?
Axel Karow et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD)
Karl Sotlar et al.
JOURNAL OF PATHOLOGY (2010)
ALK fusion genes in children with atypical myeloproliferative leukemia
S. Roettgers et al.
LEUKEMIA (2010)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman et al.
BLOOD (2009)
Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy
Carolyn J. Owen et al.
BLOOD (2008)
Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias
J. Gotlib et al.
LEUKEMIA (2008)
The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features
A. Orazi et al.
LEUKEMIA (2008)
Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasm
Falko Fend et al.
LEUKEMIA RESEARCH (2008)
Fusion of FIP1L1 and RARA as a result of a novel t(4;17)(q12;q21) in a case of juvenile myelomonocytic leukemia
A. Buijs et al.
LEUKEMIA (2007)
Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the WHO classification based on prognostic significance of morphological features in patients with refractory anemia according to the FAB classification
A. Matsuda et al.
LEUKEMIA (2007)
Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de Novo disease
Sa A. Wang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Systemic mastocytosis (SM) associated with chronic eosinophilic leukemia (SM-CEL):: Detection of FIP1L1/PDGFRα, classification by WHO criteria, and response to therapy with imatinib
Stefan Florian et al.
LEUKEMIA RESEARCH (2006)
Staging of chronic myeloid leukemia in the imatinib era - An evaluation of the World Health Organization proposal
JE Cortes et al.
CANCER (2006)
Myelodysplastic/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a case
S Heiss et al.
HUMAN PATHOLOGY (2005)
FIP1L1-PDGFRA fusion:: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia
A Pardanani et al.
BLOOD (2004)
CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy
A Pardanani et al.
BLOOD (2003)